Advances in Anemia Therapy

Anemia, also spelled anaemia, is usually defined as a decrease in the total amount of red blood cells (RBCs) or hemoglobin in the blood. It can also be defined as a lowered ability of the blood to carry oxygen. When anemia comes on slowly, the symptoms are often vague and may include feeling tired, weakness, shortness of breath or a poor ability to exercise. Anemia that comes on quickly often has greater symptoms, which may include confusion, feeling like one is going to pass out, loss of consciousness, or increased thirst. Anemia must be significant before a person becomes noticeably pale. Additional symptoms may occur depending on the underlying cause. Anemia is the most common disorder of the blood, affecting about a quarter of the people globally. Iron-deficiency anemia affects nearly 1 billion. In 2013, anemia due to iron deficiency resulted in about 183,000 deaths – down from 213,000 deaths in 1990. It is more common in females than males, among children, during pregnancy, and in the elderly. Anemia increases costs of medical care and lowers a person’s productivity through a decreased ability to work.


In the present book, fifteen typical literatures about anemia therapy published on international authoritative journals were selected to introduce the worldwide newest progress, which contains reviews or original researches on medical science, hematopathology, hematology, epidemiology, ect. We hope this book can demonstrate advances in anemia therapy as well as give references to the researchers, students and other related people.

Components of the Book:
  • Chapter 1
    Iron Deficiency or Anemia of Inflammation?
  • Chapter 2
    Anemia in a Middle Aged Female with Aortitis: A Case Report
  • Chapter 3
    Anemia, Diet and Therapeutic Iron among Children Living with HIV: A Prospective Cohort Study
  • Chapter 4
    Qualitative and Quantitative Validation of the FACIT-Fatigue Scale in Iron Deficiency Anemia
  • Chapter 5
    Anemia and Red Blood Cell Transfusion in Critically Ill Cardiac Patients
  • Chapter 6
    Cost-Utility of Ferric Carboxymaltose (Ferinject®) for Iron-Deficiency Anemia Patients with Chronic Heart Failure in South Korea
  • Chapter 7
    Anemia and Iron Deficiency in COPD Patients: Prevalence and the Effects of Correction of the Anemia with Erythropoiesis Stimulating Agents and Intravenous Iron
  • Chapter 8
    Conditioning with Rabbit versus Horse ATG Dramatically Alters Clinical Outcomes in Identical Twins with Severe Aplastic Anemia Transplanted with the Same Allogeneic Donor
  • Chapter 9
    Prevalence and Correlates of Anemia among HIV Infected Patients on Highly Active Anti-Retroviral Therapy at Zewditu Memorial Hospital, Ethiopia
  • Chapter 10
    Prevalence of Anemia Before and After Initiation of Highly Active Antiretroviral Therapy among HIV Positive Patients in Northwest Ethiopia: A Retrospective Study
  • Chapter 11
    Large Twisted Ovarian Fibroma Associated with Meigs’ Syndrome, Abdominal Pain and Severe Anemia Treated by Laparoscopic Surgery
  • Chapter 12
    Ferumoxytol versus Iron Sucrose Treatment: A Post-Hoc Analysis of Randomized Controlled Trials in Patients with Varying Renal Function and Iron Deficiency Anemia
  • Chapter 13
    Role of Preoperative Intravenous Iron Therapy to Correct Anemia before Major Surgery: Study Protocol for Systematic Review and Meta-Analysis
  • Chapter 14
    Delayed Anemia Assessment in Patients Treated with Oral Artemisinin Derivatives for Uncomplicated Malaria: A Pooled Analysis of Clinical Trials Data from Mali
  • Chapter 15
    Rationale and Design of MDOT-HuA Study: A Randomized Trial to Assess the Effect of Mobile-Directly Observed Therapy on Adherence to Hydroxyurea in Adults with Sickle Cell Anemia in Tanzania
Readership: Students, academics, teachers and other people attending or interested in Anemia Therapy.
Manfred Nairz, Department of Internal Medicine VI, Infectious Diseases, Immunology, Rheumatology, Pneumology, Medical University of Innsbruck, Anichstra?e 35, Innsbruck, Austria.

Sarah Acaster, Oxford Outcomes, 188 Embarcadero, Suite 200, San Francisco, CA 94105, USA.

Sang-Eun Choi, College of Pharmacy, Korea University, 2511 Sejong-ro, Sejong City 339-770, Korea.

P. T. Vo, Hematology Branch, National Heart Lung and Blood Institute (NHLBI), National Institute of Health (NIH), Bethesda, MD, USA.

Antonio Macciò, Department of Gynecologic Oncology, Businco Hospital, Regional Referral Center for Cancer Disease, via Edward Jenner, Cagliari 09121, Italy.

Linda J. Carroll, School of Public Health, University of Alberta, 4075 RTF, 8308 114 Street, Edmonton, Alberta T6G 2E1, Canada.

and more...
This Book

314pp. Published February 2017

Scientific Research Publishing, Inc.,USA.

Category:Biomedical & Life Sciences

ISBN: 978-1-61896-312-3

(Hardcover) USD 109.00

ISBN: 978-1-61896-311-6

(Paperback) USD 89.00

Authors/Editors Price: 40% off
Buy at: bookorder@scirp.org
Follow SCIRP
Contact us
book@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1243940697
Book Publishing WeChat
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top